KIMMTRAK (TEBENTAFUSP)

**Product type:** Human Prescription Drug

**Active ingredient:** TEBENTAFUSP

**Strength:** 100 ug/.5mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Immunocore Commercial LLC

**Marketing category:** BLA (BLA761228)

**Pharmacologic class:** Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]